ImageneBio, Inc. Current Assets
ImageneBio, Inc. (IMA) had Current Assets of $141.11 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-05
- 2026-06-30: Assets, Current $141.11M.
- 2026-03-31: Assets, Current $122.01M.
- 2025-12-31: Assets, Current $140.29M.
- 2025-09-30: Assets, Current $147.53M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $141.11M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $122.01M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $140.29M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $147.53M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $99.01M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $117.00M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $12.47M 10-K · filed 2026-03-10 | $127.17M 10-K · filed 2025-03-06 |
| 2024-09-30 | $141.53M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $149.32M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $161.17M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $178.66M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $200.63M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $160.65M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $141.18M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $160.01M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $177.98M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $199.15M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $216.05M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $236.52M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $251.87M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $268.71M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $283.23M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $165.97M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |